Rentabilidad y seguridad de la criobiopsia transbronquial mediastínica guiada por ultrasonografía endobronquial (CRYO-EBUS) en 110 casos
Medicina Clínica, ISSN: 0025-7753, Vol: 163, Issue: 4, Page: 183-185
2024
- 1Citations
- 7Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
La aspiración transbronquial con aguja guiada por ultrasonografía endobronquial (EBUS-TBNA) tiene el inconveniente de ofrecer en ocasiones unas muestras de tamaño no idóneo para un diagnóstico histo-molecular precisos. La criobiopsia mediastínica transbronquial (CRYO-EBUS), es una técnica muy novedosa y adicional a la EBUS-TBNA que nos permite obtener muestras de mayor tamaño y calidad, mejorarando el rendimiento diagnóstico. Estudio descriptivo de 110 pacientes con lesiones y/o adenopatías mediastínicas a los que se les realizó EBUS-TBNA y CRYO-EBUS en un solo procedimiento. Nuestro objetivo fue analizar la rentabilidad diagnóstica y seguridad de la técnica. El CRYO-EBUS obtuvo muestras de 0,42 cm de media frente a 0,14 cm obtenidas por EBUS-TBNA. El rendimiento diagnóstico global de las técnicas fue del 60% para el EBUS-TBNA y del 94,5% para el CRYO-EBUS. Además, este último fue más sensible tanto para el diagnóstico de enfermedades malignas como benignas, con un perfil de seguridad muy alto. La técnica CRYO-EBUS resulta rentable y segura, y es superior a EBUS-TBNA. Futuros estudios pueden confirmar nuestros hallazgos. Transbronchial needle aspiration guided by endobronchial ultrasonography (EBUSTBNA) has the disadvantage of sometimes offering samples of an unsuitable size for an accurate histo-molecular diagnosis. Transbronchial mediastinal cryobiopsy (CRYOEBUS) is a very novel and additional technique to EBUS-TBNA that allows us to obtain larger and quality samples, improving diagnostic performance. Descriptive study of 110 patients with lesions and/or mediastinal lymphadenopathy who underwent EBUS-TBNA and CRYO-EBUS in a single procedure. Our objective was to analyze the diagnostic profitability and safety of the technique. CRYO-EBUS obtained samples of 0.42 cm on average compared to 0.14 cm obtained by EBUS-TBNA. The overall diagnostic performance of the techniques was 60% for EBUS-TBNA and 94.5% for CRYO-EBUS. Furthermore, the latter was more sensitive for the diagnosis of both malignant and benign diseases. With a very high security profile. The CRYO-EBUS technique is cost-effective and safe, and is superior to EBUS-TBNA. Future studies may confirm our findings.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0025775324002719; http://dx.doi.org/10.1016/j.medcli.2024.03.011; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85195858709&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/38880730; https://linkinghub.elsevier.com/retrieve/pii/S0025775324002719; https://dx.doi.org/10.1016/j.medcli.2024.03.011
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know